Clinical evidence for medtech — delivered end‑to‑end, or exactly where you need us.
Clinical Research Solutions is a clinician-led UK contract research organisation for medical device and medtech trials. Commission us to run your entire study, or bring us in for specific parts of it and keep the rest in-house. Either way, the work is built around your budget.
One team that can run your whole trial — or slot into the parts you keep in-house.
Most sponsors don't need the same thing. Some want a single partner to carry the entire study. Others have an internal team and need cover for one or two functions. We do both, and we scale with you as the trial changes.
Full-service delivery
We run the whole trial end-to-end — one team, one point of contact. From protocol and study design through regulatory approvals, site management, monitoring, data and reporting.
Flexible support
You keep control of the trial and bring us in only for the parts you need help with. Pay for the specific functions, scale up or down as things change, and keep everything else in-house.
Not sure which fits? Tell us your budget and timeline — we'll tell you honestly what you do and don't need.
Signature experience in medtech and medical devices.
We're embedded in the NHS — not renting access to it.
Our team have worked inside the NHS delivering research for years. Our medical director is a practising NHS GP, and our route into primary care runs through the Primary Care Research Alliance (PCRA), the UK's largest GP-led research network. That's why sites open faster and studies run inside routine care pathways, instead of new infrastructure built from scratch.
“Clinical Research Solutions has earned genuinely strong relationships with our research sites. Because CRS understand clinical research delivery as well as being an excellent CRO, they mobilise practices quickly, brief investigators properly, and protect data quality at every site. It's a level of site engagement we're proud to enable across the Alliance.”
“Clinical Research Solutions has been an exceptional partner in supporting our MHRA-regulated trials within Portsmouth Hospitals University NHS Trust. Their professionalism, responsiveness, and in-depth knowledge of clinical trial governance have been invaluable at every stage — from protocol development and regulatory submissions to site management and data integrity.”
Clinicians who run trials — not a marketing agency.
Clinician-led
Our CEO is a research nurse; our medical director is an NHS GP of 20 years. Practising GPs and nurses on the team.
Built for every budget
Take the whole service or just the parts you need. We're honest about what will and won't move the study forward.
Right-sized regulation
Where appropriate we use service evaluation routes that gather real-world evidence without full trial approval — faster, and less costly.
Real NHS reach
Direct embedding in NHS primary and secondary care means faster site identification and no site set-up lag.
The things medtech founders actually ask us.
What's the difference between hiring you for the whole trial versus just parts of it?
With full-service delivery we run the entire trial end-to-end — one team, one point of contact. With flexible support you keep control and bring us in only for the specific functions you need, such as site monitoring, data management, statistics, ethics and regulatory paperwork, or quality oversight — paid for only as needed.
How can a medtech company reduce the cost of a UK clinical trial?
Three levers: smart regulatory classification (using service evaluation or quality improvement routes where appropriate, which can avoid full research ethics approval), direct embedding in NHS primary care so there's no site set-up lag, and paying only for the specific support you need. We tie every cost claim to a real project, not a generic comparison.
Is your flexible model what the industry calls FSP?
Yes — in the industry this is sometimes called FSP, or functional service provision. At CRS it means you keep overall control of the trial and bring us in for defined functions only, scaled up or down as the trial changes.
Tell us your challenges and goals, and how we can help.
We'll tell you the fastest, most cost-effective route to the evidence you need — and exactly how much of it we should run.